Towards revealing the structure of bacterial inclusion bodies

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Prion

• Publication date

  2009-07-01

• Fields of study

  Biology, Medicine, Materials Science

• Identifiers
  DOI 10.4161/pri.3.3.9922PMID 19806034PMCID PMC2802778
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Structure–activity relationship of amyloid fibrils

  2009cited by this paper
• Widespread Abundance of Functional Bacterial Amyloid in Mycolata and Other Gram-Positive Bacteria

  2009cited by this paper
• In Brief

  2009cited by this paper
• Amyloids in bacterial inclusion bodies.

  2009cited by this paper
• Solid-state NMR spectroscopy reveals that E. coli inclusion bodies of HET-s(218-289) are amyloids.

  2009cited by this paper
• Bacterial Inclusion Bodies Contain Amyloid-Like Structure

  2008cited by this paper
• Polymorphism in an amyloid-like fibril-forming model peptide.

  2008cited by this paper
• Production of Nonclassical Inclusion Bodies from Which Correctly Folded Protein Can Be Extracted

  2008cited by this paper
• Studies on bacterial inclusion bodies.

  2008cited by this paper
• Amyloid Fibrils of the HET-s(218–289) Prion Form a β Solenoid with a Triangular Hydrophobic Core

  2008cited by this paper
• Inclusion bodies: specificity in their aggregation process and amyloid-like structure.

  2008cited by this paper
• The fold of α-synuclein fibrils

  2008cited by this paper
• The surface layer protein of Bacillus thuringiensis CTC forms unique intracellular parasporal inclusion body

  2008cited by this paper
• Fourier transform infrared spectroscopy analysis of the conformational quality of recombinant proteins within inclusion bodies

  2008cited by this paper
• New properties of inclusion bodies with implications for biotechnology

  2008cited by this paper
• Engineering inclusion bodies for non denaturing extraction of functional proteins

  2008cited by this paper
• Amyloid as a Depot for the Formulation of Long-Acting Drugs

  2008cited by this paper
• Native conformation at specific residues in recombinant inclusion body protein in whole cells determined with solid-state NMR spectroscopy.

  2008cited by this paper
• Amyloidogenesis of Type III-dependent Harpins from Plant Pathogenic Bacteria*

  2007cited by this paper
• Atomic structures of amyloid cross-β spines reveal varied steric zippers

  2007cited by this paper
• Mycobacterium tuberculosis produces pili during human infection

  2007cited by this paper
• Refolding and Structural Characteristic of TRAIL/Apo2L Inclusion Bodies from Different Specific Growth Rates of Recombinant Escherichia coli

  2007cited by this paper
• Evaluation of different culture conditions for high-level soluble expression of human cyclin A2 with pET vector in BL21 (DE3) and spectroscopic characterization of its inclusion body structure.

  2007cited by this paper
• Recombinant protein solubility—does more mean better?

  2007cited by this paper
• Solid-state NMR structural measurements on the membrane-associated influenza fusion protein ectodomain.

  2007cited by this paper
• Atomic structures of amyloid cross-beta spines reveal varied steric zippers.

  2007cited by this paper
• Amyloid-linked cellular toxicity triggered by bacterial inclusion bodies.

  2007cited by this paper
• The physical basis of how prion conformations determine strain phenotypes

  2006cited by this paper
• How evolutionary pressure against protein aggregation shaped chaperone specificity.

  2006cited by this paper
• Localization of Functional Polypeptides in Bacterial Inclusion Bodies

  2006cited by this paper
• Microbial Cell Factories the Chaperone Dnak Controls the Fractioning of Functional Protein between Soluble and Insoluble Cell Fractions in Inclusion Body-forming Cells

  2006cited by this paper
• Protein aggregation and amyloidosis: confusion of the kinds?

  2006cited by this paper
• Protein quality in bacterial inclusion bodies.

  2006cited by this paper
• Structure of the ternary signaling complex of a TGF-β superfamily member

  2006cited by this paper
• Structural analysis of protein inclusion bodies by Fourier transform infrared microspectroscopy.

  2006cited by this paper
• 13C, 15N Resonance Assignment of Parts of the HET-s Prion Protein in its Amyloid Form

  2006influential reference
• Kinetics of inclusion body formation studied in intact cells by FT‐IR spectroscopy

  2005cited by this paper
• Structure of the cross-beta spine of amyloid-like fibrils.

  2005influential reference
• Solubilization and refolding of bacterial inclusion body proteins.

  2005cited by this paper
• Correlation of structural elements and infectivity of the HET-s prion

  2005influential reference
• Self-propagating, molecular-level polymorphism in Alzheimer's beta-amyloid fibrils.

  2005cited by this paper
• Sequence determinants of protein aggregation: tools to increase protein solubility

  2005cited by this paper
• Attacking amyloid.

  2005cited by this paper
• Aggregation of a slow-folding mutant of a beta-clam protein proceeds through a monomeric nucleus.

  2005cited by this paper
• Amyloid-like properties of bacterial inclusion bodies.

  2005cited by this paper
• Nondenaturing solubilization of beta2 microglobulin from inclusion bodies by L-arginine.

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-β(1–42) fibrils

  2005cited by this paper
• 3D structure of Alzheimer's amyloid-beta(1-42) fibrils.

  2005influential reference
• Structure and function of the complex formed by the tuberculosis virulence factors CFP‐10 and ESAT‐6

  2005cited by this paper
• Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

  2005cited by this paper
• Structural characteristics and refolding of in vivo aggregated hyperthermophilic archaeon proteins

  2004cited by this paper
• Folding proteins in fatal ways

  2003cited by this paper
• The crystal structure of myelin oligodendrocyte glycoprotein, a key autoantigen in multiple sclerosis

  2003cited by this paper
• Protein folding and misfolding

  2003cited by this paper
• RefDB: A database of uniformly referenced protein chemical shifts

  2003cited by this paper
• A novel class of secreted hydrophobic proteins is involved in aerial hyphae formation in Streptomyces coelicolor by forming amyloid-like fibrils.

  2003cited by this paper
• Domain organization and structure–function relationship of the HET‐s prion protein of Podospora anserina

  2003cited by this paper
• Role of molecular chaperones in inclusion body formation

  2003cited by this paper
• Structural insights into the antigenicity of myelin oligodendrocyte glycoprotein

  2003cited by this paper
• Amyloid aggregates of the HET-s prion protein are infectious

  2002cited by this paper
• The HET-s Prion Protein of the Filamentous Fungus Podospora anserina Aggregates in Vitro into Amyloid-like Fibrils*

  2002cited by this paper
• A structural model for Alzheimer's beta -amyloid fibrils based on experimental constraints from solid state NMR.

  2002cited by this paper
• Role of Escherichia coli Curli Operons in Directing Amyloid Fiber Formation

  2002cited by this paper
• Review: history of the amyloid fibril.

  2000cited by this paper
• Fine architecture of bacterial inclusion bodies

  2000cited by this paper
• Crystal structure of human bone morphogenetic protein-2 at 2.7 A resolution.

  1999cited by this paper
• Quantification of beta-sheet amyloid fibril structures with thioflavin T.

  1999cited by this paper
• Staining methods for identification of amyloid in tissue.

  1999cited by this paper
• Trigger factor and DnaK cooperate in folding of newly synthesized proteins

  1999cited by this paper
• Dynamics of in vivo protein aggregation: building inclusion bodies in recombinant bacteria.

  1998cited by this paper
• Protein aggregation: folding aggregates, inclusion bodies and amyloid.

  1998cited by this paper
• The protein product of the het-s heterokaryon incompatibility gene of the fungus Podospora anserina behaves as a prion analog.

  1997cited by this paper
• Common core structure of amyloid fibrils by synchrotron X-ray diffraction.

  1997influential reference
• Folding of a Mutant Maltose-binding Protein of Escherichia coli Which Forms Inclusion Bodies (*)

  1996cited by this paper
• Specific aggregation of partially folded polypeptide chains: The molecular basis of inclusion body composition

  1996cited by this paper
• Thermolabile folding intermediates: inclusion body precursors and chaperonin substrates

  1996cited by this paper
• Nativelike secondary structure in interleukin-1 beta inclusion bodies by attenuated total reflectance FTIR.

  1994cited by this paper
• Secondary structure characterization of beta-lactamase inclusion bodies.

  1994cited by this paper
• Inclusion body formation and protein stability in sequence variants of interleukin-1 beta.

  1993cited by this paper
• Protein engineering.

  1992cited by this paper
• Protein compositional analysis of inclusion bodies produced in recombinant Escherichia coli

  1992cited by this paper
• Structure and Morphology of Protein Inclusion Bodies in Escherichia Coli

  1991cited by this paper
• X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.

  1986influential reference
• The X-ray interpretation of denaturation and the structure of the seed globulins.

  1935influential reference

• Surpassing protein specificity in biomimetics of bacterial amyloids.

  2025cites this paper
• A distributed-parameter observer for estimating the distribution of concentrations in a tubular protein refolding reactor

  2025cites this paper
• Inclusion Bodies: Status Quo and Perspectives.

  2023cites this paper
• Carrier‐Free Enzyme Immobilizates for Flow Chemistry

  2023cites this paper
• Bioprocessing of inclusion bodies from E. coli. to prosduce bioactive recombinant proteins

  2023cites this paper
• Lactiplantibacillus plantarum: a new example of inclusion body producing bacteria

  2023cites this paper
• Oligomerization and Adjuvant Activity of Peptides Derived from the VirB4-like ATPase of Clostridioides difficile

  2023cites this paper
• Optimization of Inclusion Body Formation and Purification in Multi-well Plates.

  2023cites this paper
• Bioprocessing of recombinant proteins from Escherichia coli inclusion bodies: insights from structure-function relationship for novel applications

  2022cites this paper
• Recombinant Protein Production and Purification of Insoluble Proteins.

  2022cites this paper
• Expression of membrane beta-barrel protein in E. coli at low temperatures: Structure of Yersinia pseudotuberculosis OmpF porin inclusion bodies.

  2022cites this paper
• Challenges Associated With the Formation of Recombinant Protein Inclusion Bodies in Escherichia coli and Strategies to Address Them for Industrial Applications

  2021cites this paper
• Bioinformatic analysis and genetic engineering approaches for recombinant biopharmaceutical glycoproteins production in microalgae

  2021cites this paper
• Studies on the Structure and Properties of Membrane Phospholipase A1 Inclusion Bodies Formed at Low Growth Temperatures Using GFP Fusion Strategy

  2021cites this paper
• Emerging Solutions for in Vivo Biocatalyst Immobilization: Tailor-Made Catalysts for Industrial Biocatalysis

  2021cites this paper
• Structure-Function Relationship of Inclusion Bodies of a Multimeric Protein

  2020cites this paper
• IGF1 inclusion bodies: a QbD based process approach for efficient USP as well as early DSP unit operations.

  2020cites this paper
• Interplay of isoform 1N4R tau protein and amyloid-β peptide fragment 25-35 in reducing and non-reducing conditions.

  2020cites this paper
• Thermostable adenosine 5′-monophosphate phosphorylase from Thermococcus kodakarensis forms catalytically active inclusion bodies

  2020cites this paper
• Effect of chemically defined growth medium components on characteristics of bacterial inclusion bodies

  2020cites this paper
• Targeting Antitumoral Proteins to Breast Cancer by Local Administration of Functional Inclusion Bodies

  2019cites this paper
• Protein Refolding/Renaturation

  2019cites this paper
• Tailoring the properties of (catalytically)-active inclusion bodies

  2019cites this paper
• A method of predicting the in vitro fibril formation propensity of Aβ40 mutants based on their inclusion body levels in E. coli

  2019cites this paper
• Characterization of the enzymes involved in the diolsynthase pathway in Pseudomonas aeruginosa

  2019cites this paper
• Expression, solubilisation, purification and characterisation of recombinant bluetongue virus viral protein 7

  2018cites this paper
• Magnetization of active inclusion bodies: comparison with centrifugation in repetitive biotransformations

  2018cites this paper
• Application of an E. coli signal sequence as a versatile inclusion body tag

  2017cites this paper
• Proteins behaving badly. Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting.

  2017cites this paper
• Integrated process development—a robust, rapid method for inclusion body harvesting and processing at the microscale level

  2017cites this paper
• Bacterial Inclusion Bodies: Discovering Their Better Half.

  2017cites this paper
• Catalytically-active inclusion bodies-Carrier-free protein immobilizates for application in biotechnology and biomedicine.

  2017cites this paper
• Etiologic Framework for the Study of Neurodegenerative Disorders as Well as Vascular and Metabolic Comorbidities on the Grounds of Shared Epidemiologic and Biologic Features

  2016cites this paper
• Production strategies for active heme-containing peroxidases from E. coli inclusion bodies – a review

  2016cites this paper
• Strain conformation controls the specificity of cross-species prion transmission in the yeast model

  2016cites this paper
• Enhancing the Yield of Active Recombinant Chitobiase by Physico-Chemical and In Vitro Refolding Studies

  2016cites this paper
• Substoichiometric molecular control and amplification of the initiation and nature of amyloid fibril formation: lessons from and for blood clotting

  2016cites this paper
• Combining in Vitro Folding with Cell Free Protein Synthesis for Membrane Protein Expression.

  2016cites this paper
• Development and optimization of topical antimicrobial agents based on human antimicrobial peptides

  2016cites this paper
• Rational Design of a Carrier Protein for the Production of Recombinant Toxic Peptides in Escherichia coli

  2016cites this paper
• Insoluble Proteins

  2015cites this paper
• Self‐Assembled Proteins and Peptides as Scaffolds for Tissue Regeneration

  2015cites this paper
• Two distinct conformational states of Mycobacterium tuberculosis virulent factor early secreted antigenic target 6 kDa are behind the discrepancy around its biological functions

  2015cites this paper
• Determinants of amyloid fibril degradation by the PDZ protease HTRA1.

  2015cites this paper
• Overexpressed Arabidopsis Annexin4 accumulates in inclusion body-like structures.

  2015cites this paper
• Human recombinant lysosomal enzymes produced in microorganisms.

  2015cites this paper
• A role for hnRNPUL2 in linking the management of DNA topology with the DNA damage response

  2015cites this paper
• Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process

  2015cites this paper
• Characterization of the 4,6-α-glucanotransferase GTFB enzyme of Lactobacillus reuteri 121 isolated from inclusion bodies

  2015cites this paper
• General introduction: recombinant protein production and purification of insoluble proteins.

  2015cites this paper
• TDP-43 Inclusion Bodies Formed in Bacteria Are Structurally Amorphous, Non-Amyloid and Inherently Toxic to Neuroblastoma Cells

  2014cites this paper
• Screening for amyloid aggregation: in-silico, in-vitro and in-vivo detection.

  2014cites this paper
• Inclusion Bodies in the Study of Amyloid Aggregation

  2014cites this paper
• Use of polyomics approaches to understanding drug resistance in kinetoplatid protozoa

  2014cites this paper
• Thermodynamics, kinetics and inclusion body formation of a de novo designed protein Threefoil

  2014influential citation
• Stability and cytotoxicity of crystallin amyloid nanofibrils.

  2014cites this paper
• A variant of green fluorescent protein exclusively deposited to active intracellular inclusion bodies

  2014cites this paper
• Effect of Culture Conditions and Signal Peptide on Production of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase in Escherichia coli BL 21

  2013cites this paper
• Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells

  2013cites this paper
• Effect of culture conditions and signal peptide on production of human recombinant N-acetylgalactosamine-6-sulfate sulfatase in Escherichia coli BL21.

  2013cites this paper
• Supramolecular organization of protein-releasing functional amyloids solved in bacterial inclusion bodies.

  2013cites this paper
• Characterization of intracellular protein aggregates

  2013influential citation
• Effect of Culture Conditions and Signal Peptide on Production of Human Recombinant N-Acetylgalactosamine-6-Sulfate Sulfatase in Escherichia coli

  2013cites this paper
• [In vitro renaturation of proteins from inclusion bodies].

  2012cites this paper
• Phenotypic characterization of cells participating in transport of prion protein aggregates across the intestinal mucosa of sheep

  2012cites this paper
• Emerging Trends in Designing Short and Efficient Protein Purification Protocols

  2012cites this paper
• A HupS-GFP fusion protein demonstrates a heterocyst-specific localization of the uptake hydrogenase in Nostoc punctiforme.

  2011cites this paper
• Analytical approaches for assessing aggregation of protein biopharmaceuticals.

  2011cites this paper
• Solid-state nuclear magnetic resonance (NMR) spectroscopy of human immunodeficiency virus gp41 protein that includes the fusion peptide: NMR detection of recombinant Fgp41 in inclusion bodies in whole bacterial cells and structural characterization of purified and membrane-associated Fgp41.

  2011cites this paper
• Effects of l-arginine on refolding of lysine-tagged human insulin-like growth factor 1 expressed in Escherichia coli

  2011cites this paper
• Open Access RESEARCH

  2010cites this paper
• The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation.

  2010cites this paper
• Quality control of inclusion bodies in Escherichia coli

  2010cites this paper
• Protein folding and aggregation in bacteria

  2010cites this paper
• Multidimensional structure-activity relationship of a protein in its aggregated states.

  2010cites this paper
• Amyloid-Like Protein Inclusions in Tobacco Transgenic Plants

  2010cites this paper
• Mini Review Article

  year unknowncites this paper